# Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.

> **NCT05173584** · PHASE4 · UNKNOWN · sponsor: **University of Aleppo** · enrollment: 30 (estimated)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** Levalbuterol
- **DRUG:** Albuterol

## Key facts

- **NCT ID:** NCT05173584
- **Lead sponsor:** University of Aleppo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-04
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05173584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05173584, "Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05173584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*